J&J CEO Joaquin Duato on Obesity, Cancer and AI | The David Rubenstein Show
Johnson & Johnson CEO Joaquin Duato says the company has no plans to enter the obesity market, instead focusing on areas such as cancer. He says oncology remains one of J&J's core growth pillars, and highlights dementia as another major challenge…
Read the full story at Bloomberg Markets ↗
ImpactNotable 40/100
Why it mattersRule-based estimate: event keywords (+6); trust 9/10.
RegionsGlobal
Published2 h ago (Thu, 08 Oct 2026 14:25:38 GMT)
RetrievedThu, 08 Oct 2026 15:00:16 GMT via rss
ClassifiedThu, 08 Oct 2026 15:00:29 GMT by heuristic